Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO in South Korea
SALT LAKE CITY, Oct. 31, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics throu…
